Odyssey Health (ODYY) Non Operating Interest Expenses (2014 - 2026)

Odyssey Health has reported Non Operating Interest Expenses for 13 years, with the latest figure at $527551.0 in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 759.27% year-over-year to $527551.0 in Q2 2026; TTM through Apr 2026 was $1.1 million, a 294.46% increase from a year earlier, with the FY2025 full-year figure at $252516.0, down 51.3% from the prior year.
• Non Operating Interest Expenses was $527551.0 for Q2 2026 at Odyssey Health, up from $412429.0 in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $527551.0 in Q2 2026, with the low at $58905.0 in Q3 2025.
• Average Non Operating Interest Expenses over 5 years is $168874.4, with a median of $150388.5 recorded in 2023.
• The sharpest annual moves came in 2022 and 2026: Non Operating Interest Expenses sank 67.12% in 2022, then surged 759.27% in 2026.
• Over 5 years, Non Operating Interest Expenses stood at $71302.0 in 2022, then jumped by 167.68% to $190861.0 in 2023, then plunged by 63.96% to $68781.0 in 2024, then surged by 38.61% to $95336.0 in 2025, then jumped by 453.36% to $527551.0 in 2026.
• The last three Non Operating Interest Expenses figures came in at $527551.0 (Q2 2026), $412429.0 (Q1 2026), and $95336.0 (Q4 2025), per Business Quant data.